Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
Alzheimers Res Ther. 2022 Sep 14;14(1):131.
doi: 10.1186/s13195-022-01025-4.
1 Department of Psychosomatic Medicine, Clinical Dementia Research, Faculty of Medicine, Rostock University, Rostock, Germany. fatemah.sakr@med.uni-rostock.de.
2 German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany. fatemah.sakr@med.uni-rostock.de.
3 German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
4 AXA Research Fund and Sorbonne University Chair, Paris, France.
5 Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France.
6 Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France.
7 Department of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France.
8 Qynapse, Paris, France.
9 Sorbonne University, UPMC University Paris 06, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, F-75013, Paris, France.
10 Multi-center Neuroimaging Platform.
11 Department of Nuclear Medicine, Pitié-Salpêtrière Hospital, AP-HP, F-75013, Paris, France.
12 Department of Neurology, University Medical Center of the Johannes-Gutenberg-University Mainz, Langenbeck str, 155131, Mainz, Germany.
13 Centre de NeuroImagerie de Recherche (CENIR), Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France.
14 Department of Neuroradiology, Salpêtriere Hospital, Paris, France.
15 Department of Psychosomatic Medicine, Clinical Dementia Research, Faculty of Medicine, Rostock University, Rostock, Germany.